Dicerna Pharmaceuticals Inc (DRNA)

Common Stock

38.22  +0.22 (+0.58%)

After market: 38.24 +0.02 (+0.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2021-9-30)		 2020
(2020-12-31)		 2019
(2019-12-31)		 2018
(2018-12-31)		 2017
(2017-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-124.35M-112.70M-120.50M-88.90M-60.20M
Depreciation Amortization
4.54M2.20M1.30M800.00K800.00K
Change In Working Capital
74.98M232.70M100.70M89.30M6.40M
Interest Paid
N/AN/AN/AN/AN/A
Other non cash items
65.89M52.90M17.80M17.10M7.70M
OPERATING CASH FLOW
21.05M175.10M-700.00K18.30M-45.30M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-12.44M-11.70M-6.30M-400.00K-100.00K
Other Investing Activity
-79.30M-247.10M55.90M-202.40M-19.70M
INVESTING CASH FLOW
-91.84M-258.90M49.50M-202.70M-19.90M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/AN/AN/AN/A
Stock Issued/Repurchased
33.61M59.60M52.90M170.60M113.50M
Dividend Paid
N/AN/AN/A0.00N/A
Other Financing Activity
-2.04M-100.00K-100.00K-700.00K-800.00K
FINANCING CASH FLOW
31.48M59.40M52.90M169.90M112.70M
 
CHANGE IN CASH
-39.31M-24.40M101.70M-14.50M47.50M
 
FREE CASH FLOW
Operating Cash Flow
21.05M175.10M-700.00K18.30M-45.30M
Capital Expenditure
-12.44M-11.70M-6.30M-400.00K-100.00K
FREE CASH FLOW
8.61M163.40M-7.00M17.90M-45.40M

All data in USD

Charts